Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

PROCEPT BioRobotics

Biotech & Life Sciences · Redwood City, United States · Founded 2009 · IPO 2021 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.03B
Market cap · Apr/2026
Revenue
$308M
Latest reported FY

Investors

8 investors on PROCEPT BioRobotics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Global footprint

Where PROCEPT BioRobotics has talent and traffic

AI talent share
0.6% of workforce is AI talent
(5 of 865 staff)
Core AI20.23%
Other AI30.35%
Non-AI workforce86099.42%
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States63.9%
🇮🇳 India20.6%
🇨🇦 Canada7.2%
🇯🇵 Japan5%
🇬🇧 United Kingdom3.3%
Top 5 markets shown

Patent intelligence

$52M patent portfolio · 34 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value
$52M
5.1% of market cap · 17.8× smaller than top peer Globus Medical ($930M)
34 active patent families
Where PROCEPT BioRobotics innovates Biomedical engineeringReoperative surgeryUser interfaceTreatment planMedical physics

Tech-focus vs peers

Where PROCEPT BioRobotics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across PROCEPT BioRobotics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See PROCEPT BioRobotics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.